Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jasmine Becerra"'
Autor:
Emily Morell, Elizabeth Colglazier, Jasmine Becerra, Leah Stevens, Martina A. Steurer, Anshuman Sharma, Hung Nguyen, Irfan S. Kathiriya, Stephen Weston, David Teitel, Roberta Keller, Elena K. Amin, Hythem Nawaytou, Jeffrey R. Fineman
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Cardiac catheterization remains the gold standard for the diagnosis and management of pediatric pulmonary hypertension (PH). There is lack of consensus regarding optimal anesthetic and airway regimen. This retrospective study describes the a
Externí odkaz:
https://doaj.org/article/d29abfe687d84f25b35c00ab08767704
Autor:
Elizabeth Colglazier, Angelica J. Ng, Claire Parker, David Woolsey, Raymond Holmes, Allison Dsouza, Jasmine Becerra, Leah Stevens, Hythem Nawaytou, Roberta L. Keller, Jeffrey R. Fineman
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 3, Pp n/a-n/a (2023)
Abstract Inhaled iloprost (iILO) has shown efficacy in treating patients with hypoxic lung disease and pulmonary hypertension, inducing selective pulmonary vasodilation and improvement in oxygenation. However, its short elimination half‐life of 20
Externí odkaz:
https://doaj.org/article/2d88513449a147b6bdb92cfea3cc7d48
Autor:
Julia McSweeney, Elizabeth Colglazier, Jasmine Becerra, Brienne Leary, Kathleen Miller‐Reed, Stephen Walker, Katy Tillman, Melissa Magness, Michelle Ogawa, Whitney Bannon, Tisha Kivett, Emma O. Jackson, Anne Davis, Cathy Shepard, Susan Richards, Elise Whalen, Shannon Engstrand, Zachary DiPasquale, Jean A. Connor
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 2, Pp n/a-n/a (2023)
Abstract Continuous subcutaneous (SubQ) treprostinil is an effective therapy for pediatric patients diagnosed with pulmonary hypertension (PH). To date, the clinical characteristics and factors associated with failure to tolerate this therapy have no
Externí odkaz:
https://doaj.org/article/d2fc43a93d194f25a4bff2c0c00d1da7
Autor:
Elizabeth Colglazier, Leah Stevens, Claire Parker, Hythem M. Nawaytou, Elena K. Amin, Jasmine Becerra, Martina Steurer, Jeffrey R. Fineman
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 4, Pp n/a-n/a (2022)
Abstract Despite the increase in therapeutic options, parenteral prostacyclins remain the cornerstone in the medical management of pulmonary arterial hypertension (PAH). While the use of parenteral prostacyclins in pediatric patients is well document
Externí odkaz:
https://doaj.org/article/03616419f5be40c295373339b3656d14